跳至主要内容
临床试验/NCT07344597
NCT07344597尚未招募不适用

Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer

Salwa Shawky Bakeet Ali1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2026年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
Disease free survival analyzed from the date of diagnosis.

研究概览

简要总结

To compare the efficacy and safety of two hypofractionated adjuvant radiotherapy regimens 34 Gy in 10

fractions versus 40.05 Gy in 15 fractions in patients with breast cancer treated at the South Egypt Cancer

Institute.

详细描述

Female breast cancer (BC) has been the leading cause of cancer morbidity and mortality among women in the

majority of countries for decades. In 2020, there were an estimated 2.3 million new cases and 685,000 deaths

from female BC worldwide, which accounted for one in four cancer cases and one in six cancer deaths among

women.

u For women with newly diagnosed, non-metastatic breast cancer, treatment consists of a multidisciplinary

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Female patients aged ≥18 years.
  • Female or male patients with invasive carcinoma of the breast.
  • Complete microscopic excision of primary tumor.
  • Undergoing breast-conserving surgery (BCS) or modified radical mastectomy (MRM).
  • ≥ Axillary lymph nodes dissected.
  • T1_4pN0_3M0 disease.
  • Neoadjuvant or adjuvant CTH .
  • Signed informed consent and able to comply with follow up.

排除标准

  • Evidence of distant metastases.
  • Past history of malignancy.
  • Prior radiotherapy to the chest region
  • Simultaneous malignancy (except non-melanoma skin cancer or in situ cervical carcinoma)
  • Connective tissue diseases (e.g., lupus erythematosus, scleroderma)
  • Pregnancy or lactation

结局指标

主要结局

Disease free survival analyzed from the date of diagnosis.

时间窗: through study completion, an average of 1 year

local control was defined as absence of disease in the irradiated areas.recurrence were categorized as local(breast or surgical bed), regional(lymphatic drainage of axillary, supraclavicular fossa or internal mammary chain),or distant (metastasis),and any associayion of these

次要结局

  • Assessment of Acute Skin Toxicity(From start of radiotherapy through 3 months after completion of radiotherapy)
  • Assessment of Late Skin Toxicity(From 3 months after completion of radiotherapy through study completion, an average of 1 year)

研究者

发起方
Salwa Shawky Bakeet Ali
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Salwa Shawky Bakeet Ali

assiut

Assiut University

研究点 (1)

Loading locations...

相似试验